Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo.

Abstract:

:Measurement of plasma levels of two secreted platelet proteins (beta-thromboglobulin and platelet factor 4) has been suggested as a means for detecting increased platelet activation in vivo. A crucial question in the measurement is the distinction between in vivo and in vitro secretion of the proteins. One approach to this distinction is the measurement of both proteins in each sample. These proteins are present in platelets in similar amounts and are released in similar quantities, but the plasma levels of beta-thromboglobulin exceed the plasma levels of platelet factor 4. This difference in plasma level is presumably due to more rapid removal of platelet factor 4 from the plasma level, and there is suggestive evidence that the rapid removal of released platelet factor 4 is due to its binding to endothelial cells. It appears that when there is increased release of beta-thromboglobulin and platelet factor 4 in vivo, there is an increase in the ratio of plasma beta-thromboglobulin to plasma platelet factor 4 compared to that found in normal individuals, whereas when in vitro release is responsible for elevated levels, the ratio decreases. Thus measurements of both proteins in each blood sample will allow distinction between in vivo release and artefactual in vitro release.

journal_name

Blood

journal_title

Blood

authors

Kaplan KL,Owen J

subject

Has Abstract

pub_date

1981-02-01 00:00:00

pages

199-202

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

57

pub_type

杂志文章,评审

相关文献

BLOOD文献大全
  • Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro.

    abstract::Latency enables human cytomegalovirus (HCMV) to persist in the hematopoietic cells of infected individuals indefinitely and prevents clearance of the pathogen. Despite its critical importance to the viral infectious cycle, viral mechanisms that contribute to latency have not been identified. We compared the ability of...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2007-01-070078

    authors: Goodrum F,Reeves M,Sinclair J,High K,Shenk T

    更新日期:2007-08-01 00:00:00

  • Erythrocyte-endothelial cell adherence in sickle cell disorders.

    abstract::Detachment of individual sickle erythrocytes from cultured endothelial cell monolayers has been evaluated by a fluid-shearing technique in an effort to quantitate adherence at shear forces that would be anticipated in the in vivo circulation. Nonirreversibly sickled cells (non-ISC) were more adherent at normal oxygen ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Smith BD,La Celle PL

    更新日期:1986-11-01 00:00:00

  • A unique precipitating autoantibody against plasma thromboplastin antecedent associated with multiple apparent plasma clotting factor deficiencies in a patient with systemic lupus erythematosus.

    abstract::A 42-yr-old woman with systemic lupus erythematosus without bleeding diathesis developed a prolonged activated partial thromboplastin time that was not corrected by normal plasma. An inhibitor that acted rapidly and inactivated 0.5 U/ml plasma thromboplastin antecedent (PTA, factor XI) at a 1:200 plasma dilution was d...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Poon MC,Saito H,Koopman WJ

    更新日期:1984-06-01 00:00:00

  • Defective tubulin organization and proplatelet formation in murine megakaryocytes lacking Rac1 and Cdc42.

    abstract::Blood platelets are anuclear cell fragments that are essential for blood clotting. Platelets are produced by bone marrow megakaryocytes (MKs), which extend protrusions, or so-called proplatelets, into bone marrow sinusoids. Proplatelet formation requires a profound reorganization of the MK actin and tubulin cytoskelet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-03-487942

    authors: Pleines I,Dütting S,Cherpokova D,Eckly A,Meyer I,Morowski M,Krohne G,Schulze H,Gachet C,Debili N,Brakebusch C,Nieswandt B

    更新日期:2013-10-31 00:00:00

  • Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice.

    abstract::Targeting cancer stem cells is of paramount importance in successfully preventing cancer relapse. Recently, in silico screening of public gene-expression datasets identified cyclooxygenase-derived cyclopentenone prostaglandins (CyPGs) as likely agents to target malignant stem cells. We show here that Δ(12)-PGJ(3), a n...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-317750

    authors: Hegde S,Kaushal N,Ravindra KC,Chiaro C,Hafer KT,Gandhi UH,Thompson JT,van den Heuvel JP,Kennett MJ,Hankey P,Paulson RF,Prabhu KS

    更新日期:2011-12-22 00:00:00

  • Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein.

    abstract::Transcription factor GATA-2 is implicated in the survival and growth of multipotential progenitors. Here we report that the promyelocytic leukemia zinc finger (PLZF) protein can interact with GATA-2 and can modify its transactivation capacity. Fanconi anemia zinc finger (FAZF), a PLZF-homologous protein that has been ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.9.3404

    authors: Tsuzuki S,Enver T

    更新日期:2002-05-01 00:00:00

  • The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation.

    abstract::The bcr-abl chimeric messenger RNA is frequently detected in chronic myeloid leukemia (CML) patients after bone marrow transplantation. It was previously reported that the relapse risk of bcr-abl detection 6 to 12 months after transplantation was greater than 40%. This risk decreased as the time between transplantatio...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood.v98.6.1701

    authors: Radich JP,Gooley T,Bryant E,Chauncey T,Clift R,Beppu L,Edmands S,Flowers ME,Kerkof K,Nelson R,Appelbaum FR

    更新日期:2001-09-15 00:00:00

  • Myc-Miz1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpα and Cebpδ.

    abstract::c-Myc (Myc hereafter) is found to be deregulated and/or amplified in most acute myeloid leukemias (AMLs). Almost all AML cells are dependent upon Myc for their proliferation and survival. Thus, Myc has been proposed as a critical anti-AML target. Myc has Max-mediated transactivational and Myc-interacting zinc finger p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001863

    authors: Zhang L,Li J,Xu H,Shao X,Fu L,Hou Y,Hao C,Li W,Joshi K,Wei W,Xu Y,Zhang F,Dai S,Breslin P,Zhang J,Zhang J

    更新日期:2020-04-02 00:00:00

  • Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia.

    abstract::Recent studies on the immunoglobulin variable heavy chain (IgV(H)) genes have revealed that B-cell chronic lymphocytic leukemia (B-CLL) consists of at least 2 clinical entities with either somatically mutated or unmutated V(H) genes. We have analyzed the V(H) gene mutation status and V(H) gene usage in 119 B-CLL cases...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.6.2262

    authors: Tobin G,Thunberg U,Johnson A,Thörn I,Söderberg O,Hultdin M,Botling J,Enblad G,Sällström J,Sundström C,Roos G,Rosenquist R

    更新日期:2002-03-15 00:00:00

  • Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells.

    abstract::The bone and immune systems are closely related through cellular and molecular interactions. Because bone-resorbing osteoclasts (OCs) are derived from the monocyte/macrophage lineage, similar to dendritic cells (DCs), we hypothesized that OCs could serve as antigen-presenting cells (APCs) to activate T cells. In this ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-11-255026

    authors: Li H,Hong S,Qian J,Zheng Y,Yang J,Yi Q

    更新日期:2010-07-15 00:00:00

  • Biomarkers for prediction of venous thromboembolism in cancer.

    abstract::Cancer patients are at increased risk of deep vein thrombosis and pulmonary embolism. The incidence among different groups of cancer patients varies considerably depending on clinical factors, the most important being tumor entity and stage. Biomarkers have been specifically investigated for their capacity of predicti...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2013-04-460147

    authors: Pabinger I,Thaler J,Ay C

    更新日期:2013-09-19 00:00:00

  • Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells.

    abstract::Recent studies in humans have highlighted the importance of a distinct cellular entity, the plasmacytoid dendritic cell (PDC). To identify genes for which expression is restricted to human PDCs, a cDNA subtraction technique was applied using cDNA from activated monocyte-derived DCs (MDDCs) as competitor. In the 650 se...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-02-0638

    authors: Rissoan MC,Duhen T,Bridon JM,Bendriss-Vermare N,Péronne C,de Saint Vis B,Brière F,Bates EE

    更新日期:2002-11-01 00:00:00

  • Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.

    abstract::Reconstitution of cytomegalovirus (CMV)-specific CD8(+) T cells is essential to the control of CMV infection in CMV-positive recipients (R(+)) after allogeneic hematopoietic stem cell transplantation (HCT). Six-color flow cytometry was used to assess the functional profile of CMV-specific CD8(+) T cells in 62 of 178 R...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-203307

    authors: Zhou W,Longmate J,Lacey SF,Palmer JM,Gallez-Hawkins G,Thao L,Spielberger R,Nakamura R,Forman SJ,Zaia JA,Diamond DJ

    更新日期:2009-06-18 00:00:00

  • Second to none.

    abstract::In this issue of Blood, Usmani et al provide important information on second primary malignancies in patients treated with thalidomide and lenalidomide in the Arkansas total therapy trials. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-07-439158

    authors: Rajkumar SV

    更新日期:2012-08-23 00:00:00

  • Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma.

    abstract::The efficacy and safety of zanolimumab in patients with refractory cutaneous T-cell lymphoma (CTCL) have been assessed in two phase 2, multicenter, prospective, open-label, uncontrolled clinical studies. Patients with treatment refractory CD4(+) CTCL (mycosis fungoides [MF], n = 38; Sézary syndrome [SS], n = 9) receiv...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2006-12-062877

    authors: Kim YH,Duvic M,Obitz E,Gniadecki R,Iversen L,Osterborg A,Whittaker S,Illidge TM,Schwarz T,Kaufmann R,Cooper K,Knudsen KM,Lisby S,Baadsgaard O,Knox SJ

    更新日期:2007-06-01 00:00:00

  • SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells.

    abstract::Chemokine stromal derived factor 1 (SDF-1) is involved in trafficking of hematopoietic stem cells (HSCs) from the bone marrow (BM) to peripheral blood (PB) and has been found to enhance postischemia angiogenesis. This study was aimed at investigating whether SDF-1 plays a role in differentiation of BM-derived c-kit(+)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4423

    authors: De Falco E,Porcelli D,Torella AR,Straino S,Iachininoto MG,Orlandi A,Truffa S,Biglioli P,Napolitano M,Capogrossi MC,Pesce M

    更新日期:2004-12-01 00:00:00

  • Clonal expansion of lymphocytes bearing the gamma delta T-cell receptor in a patient with large granular lymphocyte disorder.

    abstract::Repeated analysis of peripheral blood lymphocytes (PBLs) from a patient with large granular lymphocytosis, neutropenia, and rheumatoid arthritis revealed that approximately 45% of PBLs displayed the following phenotype: CD3+, CD4-, CD8-, CD16+, HNK-1-, WT31-. This population was purified for further analysis by deplet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Vie H,Chevalier S,Garand R,Moisan JP,Praloran V,Devilder MC,Moreau JF,Soulillou JP

    更新日期:1989-07-01 00:00:00

  • Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma.

    abstract::Interleukin-15 (IL-15) induces proliferation and promotes cell survival of human T and B lymphocytes, natural killer cells, and neutrophils. Here we report the constitutive expression of a functional IL-15 receptor (IL-15R) in 6 of 6 myeloma cell lines and in CD38(high)/CD45(low )plasma cells belonging to 14 of 14 pat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tinhofer I,Marschitz I,Henn T,Egle A,Greil R

    更新日期:2000-01-15 00:00:00

  • Fetal erythropoiesis following bone marrow transplantation.

    abstract::"Fetal" erythrocytes are present in older children and certain adults with hematologic disorders. To determine if regenerating bone marrow produces such cells, we examined the blood of seven allogeneic bone marrow transplant recipients. Six patients were engrafted with donor cells, while on e patients recovered autolo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Alter BP,Rappeport JM,Huisman TH,Schroeder WA,Nathan DG

    更新日期:1976-12-01 00:00:00

  • Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.

    abstract::The aim of this study was to understand the impact of chronic graft-versus-host disease (cGVHD) on the overall health status of hematopoietic cell transplantation (HCT) survivors. Subjects included 584 individuals who had undergone allogeneic HCT between 1976 and 1999, survived 2 or more years, and completed a 255-ite...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-003954

    authors: Fraser CJ,Bhatia S,Ness K,Carter A,Francisco L,Arora M,Parker P,Forman S,Weisdorf D,Gurney JG,Baker KS

    更新日期:2006-10-15 00:00:00

  • Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone.

    abstract::Variations within proteasome β (PSMB) genes, which encode the β subunits of the 20S proteasome, may affect proteasome function, assembly, and/or binding of proteasome inhibitors. To investigate the potential association between PSMB gene variants and treatment-emergent resistance to bortezomib and/or long-term outcome...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2012-05-426924

    authors: Lichter DI,Danaee H,Pickard MD,Tayber O,Sintchak M,Shi H,Richardson PG,Cavenagh J,Bladé J,Façon T,Niesvizky R,Alsina M,Dalton W,Sonneveld P,Lonial S,van de Velde H,Ricci D,Esseltine DL,Trepicchio WL,Mulligan G,And

    更新日期:2012-11-29 00:00:00

  • In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation.

    abstract::Expression of B7 family costimulatory molecules on B cells defines their capacity to function as antigen presenting cells (APCs). B cells that do not express B7 costimulatory molecules induce T-cell tolerance. Therefore, the expression of B7 costimulatory molecules on malignant B cells might be critical for their reco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dorfman DM,Schultze JL,Shahsafaei A,Michalak S,Gribben JG,Freeman GJ,Pinkus GS,Nadler LM

    更新日期:1997-12-01 00:00:00

  • G6PD isoenzyme analysis of myeloid and lymphoid cells in human multilineage colonies.

    abstract::Some multilineage hemopoietic colonies contain, in addition to myeloid cells, T lymphocytes. These proliferate extensively in liquid suspension culture under the influence of a T cell growth factor provided by phytohemagglutinin-T cell-conditioned medium (PHA-TCM). The clonal origin of these myeloid and lymphoid compo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lim B,Jamal N,Tritchler D,Messner HA

    更新日期:1984-06-01 00:00:00

  • Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish.

    abstract::Isocitrate dehydrogenase 1 mutation (IDH1-R132H) was recently identified in acute myeloid leukemia with normal cytogenetics. The mutant enzyme is thought to convert α-ketoglutarate to the pathogenic 2-hydroxyglutarate (2-HG) that affects DNA methylation via inhibition of ten-eleven translocation 2. However, the role o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-09-601187

    authors: Shi X,He BL,Ma AC,Guo Y,Chi Y,Man CH,Zhang W,Zhang Y,Wen Z,Cheng T,Leung AY

    更新日期:2015-05-07 00:00:00

  • Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.

    abstract::Inhibitors of cyclin-dependent kinases (Cdks) have been reported to have activities in chronic lymphocytic leukemia cells by inhibiting Cdk7 and Cdk9, which control transcription. Here we studied the novel Cdk inhibitor SNS-032, which exhibits potent and selective inhibitory activity against Cdk2, Cdk7, and Cdk9. We h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-12-190256

    authors: Chen R,Wierda WG,Chubb S,Hawtin RE,Fox JA,Keating MJ,Gandhi V,Plunkett W

    更新日期:2009-05-07 00:00:00

  • The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

    abstract::Cytogenetics is considered one of the most valuable prognostic determinants in acute myeloid leukemia (AML). However, many studies on which this assertion is based were limited by relatively small sample sizes or varying treatment approach, leading to conflicting data regarding the prognostic implications of specific ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Grimwade D,Walker H,Oliver F,Wheatley K,Harrison C,Harrison G,Rees J,Hann I,Stevens R,Burnett A,Goldstone A

    更新日期:1998-10-01 00:00:00

  • Relationship of a leukemia-associated antigen to the presence of lymphoblasts in the peripheral blood in children with acute lymphocytic leukemia.

    abstract::Peripheral blood samples from 57 children with newly diagnosed E-rosette-negative, surface-immunoglobulin negative acute lymphocytic leukemia (ALL) were studied for the presence of a leukemia-associated antigen (ALLA). Ficoll-Hypaque separated cells were tested using a rabbit antiserum to human null lymphoblasts and a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morgan E,Hsu CC

    更新日期:1981-05-01 00:00:00

  • Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops.

    abstract::The biologic effects of endothelin-1 (ET-1) are not limited to its potent vasoconstricting activity. The endothelin receptors, ETA and ETB, have differential tissue and functional distributions. Here we showed that dendritic cells (DCs), the major antigen-presenting cells in the adaptive limb of the immune system, pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-10-3559

    authors: Guruli G,Pflug BR,Pecher S,Makarenkova V,Shurin MR,Nelson JB

    更新日期:2004-10-01 00:00:00

  • Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.

    abstract::The mechanism(s) underlying the release of stem/progenitor cells from bone marrow into the circulation is poorly understood. We hypothesized that matrix metalloproteinases (MMPs), especially gelatinases, which are believed to participate in the proteolysis of basement membranes and in the migration of leukocytes, may ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Janowska-Wieczorek A,Marquez LA,Nabholtz JM,Cabuhat ML,Montaño J,Chang H,Rozmus J,Russell JA,Edwards DR,Turner AR

    更新日期:1999-05-15 00:00:00

  • Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34- blasts from acute myelogenous leukemia.

    abstract::We studied the effects of interleukin-4 (IL-4) and IL-6 on the growth of leukemic blasts from 40 patients with acute myelogenous leukemia (AML). Patients were selected on the basis of negativity for a series of B-cell antigens including CD10 and CD19. Twenty-one cases were CD34-positive (CD34+) (greater than 15% of bl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Akashi K,Harada M,Shibuya T,Eto T,Takamatsu Y,Teshima T,Niho Y

    更新日期:1991-07-01 00:00:00